Abstract
In patients with HIV-1 infection, the nervous system is commonly affected (Snider et al. 1983; Levy et al. 1985 a; McArthur 1987; De Gans et al. 1989). Neurological involvement occurs in at least 40% of patients, who usually already meet the CDC clinical criteria for AIDS (Centers for Disease Control 1987), and it is the presenting manifestation in 10% of HIV-infected patients. At autopsy, 80%–90% are found to have neuropathological abnormalities (Anders et al. 1986). Each part of the neuraxis may be involved. Although this spectrum of neurological complications is well known and includes opportunistic infections, neoplasms, and complications caused by or related to HIV-1 itself, newly recognized clinical syndromes or atypical courses of neurological diseases in HIV-1 infected are still being reported. Some of the neurological complications occur in the early and clinically latent phases of the infection, and others are associated with advanced HIV-1 infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albert ML, Feldman RG, Willis AL (1974) The “subcortical dementia” of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37: 121–130
Anders KH, Guerra WF, Tomiyasu U et al. (1986) The neuropathology of AIDS: UCLA experience and review. Am J Pathol 124: 537–558
Arnason BGW (1975) Inflammatory polyradiculoneuropathies. In: Dyck PJ, Thomas PK, Lambert EH (eds) Peripheral neuropathy Saunders, Philadelphia, pp 1110–1149
Ästrom KE, Mancall EL, Richardson EP Jr (1958) Progressive multifocal leukoencephalopathy: a hitherto unrecognized complication of chronic lymphatic leukemia and Hodgkinss disease. Brain 81: 93–111
Balakrishnan J, Becker PS, Kumar AJ, Zinreich SJ, McArthur JC, Bryan RN (1990) Acquired immunodeficiency syndrome: correlation of radiologic and pathologic findings in the brain. Radiographics 10: 201–215
Baumgartner JE, Rachlin JR, Beckstead JH et al. (1990) Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 73: 206–211
Berger JR (1991) Neurosyphilis in human immunodeficiency virus type 1-seropositive individuals. A prospective study. Arch Neurol 48: 700–702
Berger JR, Mucke L (1988) Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 38: 1060–1065
Berger JR, Kaszovitz B, Donovan-Post J, Dickinson G (1987) Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. Ann Intern Med 107: 78–87
Berger JR, Sheramata WA, Resnick L et al. (1989) Multiple sclerosis-like illness occurring with human immunodeficiency virus infection. Neurology 39: 324–329
Berry CD, Hooton TM, Collier AC, Lukehart SA (1987) Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 316: 1587–1589
Bishburg E, Sunderam G, Reichman LB et al. (1986) Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann Intern Med 105: 210–213
Borgstein BJ, Koster PA, Portegies P, Peeters FLM (1989) Myeolography in patients with acquired immunodeficiency syndrome. Neuroradiology 31: 326–330
Bozette SA, Larsen RA, Chiu J et al. (1991) A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 324: 580–584
Brew BJ, Miller J (1991) Human immunodeficiency virus related headache (Abstr MB 2098). 7th International Conference on AIDS, Florence
Brew B J, Perdices M, Darveniza P et al. (1989a) The neurological features of early and “latent” human immunodeficiency virus infection. Aust NZ J Med 19: 700–705
Brew BJ, Bhalla RB, Fleischer M et al. (1989b) Cerebrospinal fluid beta-2 microglobulin in patients infected with human immunodeficiency virus type 1. Neurology 39: 830–834
Brew BJ, Bhalla RV, Paul M et al. (1990) CSF neopterin in HIV-1 infection. Ann Neurol 28: 556–560
Britton CB, Sisti MB, Romagnoli M et al. (1991) Intrathecal cytosine arabinoside treatment of patients with HIV-associated progressive multifocal leukoencephalopathy (PML) ( Abstr.) Neuroscience of HIV Infection Conference, Padova
Butler KM, Husson RN, Ballis FM et al. (1991) Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med 324: 137–144
Centers for Disease Control (1987) Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36:1S–15S
Centers for Disease Control (1988) Recommendations for diagnosing and treating syphilis in HIV-infected patients. MMWR 37: 600–608
Chuck SL, Sande MA (1989) Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 321: 794–799
Ciricillo SF, Rosenblum M (1990) Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg 73: 720–724
Cohen JA, Laudenslager M (1989) Autonomic nervous system involvement in patients with human immunodeficiency virus infection. Neurology 39: 1111–1112
Cooley TP, Kunches LM, Saunders CA et al. (1990) Once-daily administration of 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome of AIDS-related complex. N Engl J Med 322: 1340–1345
Cornblath DR, McArthur JC, Kennedy PGE et al. (1987) Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type II infection. Ann Neurol 21: 32–40
Cornblath DR et al. (1991) Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41: 617–618
Dalakas MC (1991) The mechanism of HIV and AZT-induced myopathy (Abstr.) Neuroscience of HIV Infection Conference, Padova
Dalakas MC, Pezenshkpour GH, Gravell M et al. (1986) Polymyositis associated with AIDS retrovirus. JAMA 256: 2381–2383
Dalakas MC, Illia I, Pezeshkpour GH et al. (1990) Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322: 1098–1105
Davis LE (1990) Neurosyphilis in the patient infected with human immunodeficiency virus. Ann Neurol 27: 211–212
De Gans J, Portegies P (1989) Neurological complications of infection with human immunodeficiency virus type 1. A review of literature and 241 cases. Clin Neurol Neurosurg 91: 197–217
De Gans J, Lange JMA, Derix MMA et al. (1988) Decline of HIV antigen levels in cerebrospinal fluid during treatment with low-dose zidovudine. AIDS 2: 37–40
De Gans J, Tiessens G, Portegies P et al. (1990 a) Predominance of polymorphonuclear leukocytes in cerebrospinal fluid in AIDS patients with cytomegalovirus polyradiculomyelitis. J Acquir Immune Defic Syndr. 3: 1155–1158
De Gans J, Portegies P, Tiessens G et al. (1990b) Therapy for cytomegalovirus polyradiculomyelitis in patients with AIDS: treatment with ganciclovir. AIDS 4: 421–425
De La Monte SM, Gabuzda DH, Ho D et al. (1988) Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol 23: 485–492
De La Paz R, Enzmann D (1988) Neuroradiology of acquired immunodeficiency syndrome. In: Rosenblum ML, Levy RM, Bredesen DE (eds.) AIDS and the nervous system. Raven, New York, pp. 121–153
Denning DW, Tucker RM, Hanson LH et al. (1989) Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 149: 2301–2308
Dina TS (1991) Primary central nervous system lymphoma versus toxoplasmosis in AIDS. Radiology 179: 823–828
Dismukes WE (1988) Cryptococcal meningitis in patients with AIDS. J Infect Dis 157: 624–628
Dix RD, Bredesen DE (1988) Opportunistic viral infections in acquired immunodeficiency syndrome. In: Rosenblum ML, Levy RM, Bredesen DE (eds.) AIDS and the nervous system. Raven, New York, pp. 221–261
Dix RD, Waitzman DM, Follansbee S et al. (1985) Herpes simplex virus type 2 encephalitis in two homosexual men with persistent lymphadenopathy. Ann Neurol 17: 203–206
Eidelberg D, Sotrel A, Vogel H et al. (1986) Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology 36: 912–916
Engstrom JW, Lowenstein DH, Bredesen DE (1989) Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome. Am J Med 86: 528–532
Everall IP, Luthert PJ, Lantos PL (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337: 1119–1121
Feraru ER, Aronow HA, Lipton RB (1990) Neurosyphilis in AIDS: initial CSF VDRL may be negative. Neurology 40: 541–543
Freeman R, Roberts M, Friedman L et al. (1990) Autonomic function and human immunodeficiency virus infection. Neurology 40: 575–580
Fuller GN, Jacobs JM, Guillof RJ (1989) Association of painful peripheral neuropathy in AIDS with cytomegalovirus infection. Lancet 1: 937–941
Gherardi R, Lebargy F, Gaulard P et al. (1989) Necrotizing vasculitis and HIV replication in peripheral nerves. N Engl J Med 321: 685–686
Gherardi R, Mhiri C, Chariot P et al. (1991) Zidovudine myopathy: a clinical, pathological and biochemical study of 15 cases ( Abstr.) Neuroscience of HIV Infection Conference, Padova
Grant I, Atkinson J, Hesselink JR et al. (1987) Evidence for early central nervous system involvement in the acquired immunodeficiency virus (HIV) infections; studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med 107: 828–836
Gray F, Chimelli L, Mohr M et al. (1991) Fulminating multiple sclerosis-like leukoencephalopathy revealing human immunodeficiency virus infection. Neurology 41: 105–109
Hall CD, Snijder CR, Nemni R et al. (1991) Peripheral nerve function in HIV infected subjects (Abstr.) Neuroscience of HIV Infection, Padova
Heyes MP, Brew BJ, Martin A et al. (1991) Increased cerebrospinal fluid concentrations of the exotoxin quinolinic acid in human immunodeficiency virus infection and AIDS dementia complex. Ann Neurol 91: 202–209
Hicks CB, Benson PM, Lupton GP et al. (1987) Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus with Kaposi sarcoma. Ann Intern Med 107: 492–495
Hollander H, Stringari S (1987) Human immunodeficiency virus-associated meningitis: clinical course and correlations. Am J Med 83: 813–816
Holtzman DM, Kaku DA, So YT (1989) New onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med 87: 173–177
Hook EW (1989) Syphilis and HIV infection. J Infect Dis 160: 530–534
Jarvik JG, Hesselink JR, Kennedy C et al. (1988) Acquired immunodeficiency syndrome: magnetic resonance patterns of brain involvement with pathologic correlation. Arch Neurol 45: 731–736
Johns DR, Tierney M, Felsenstein D (1987) Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 316: 1569–1572
Kaplan LD, Abrams DI, Feigal E et al. (1989) AIDS-associated non-Hodgkin’s lymphoma in San Fransisco. JAMA 261: 719–724
Katlama C, de Wit S, Guichard A et al. (1991) Pyrimethamine-clindamycin (P/C) versus pyrimethamine-sulfadiazine (P/S) in Toxoplasma encephalitis in AIDS: a randomized prospective multicentric European study (Abstr WB 28). 7th International Conference on AIDS, Florence
Katz DA, Berger JR (1989) Neurosyphilis in acquired immunodeficiency syndrome. Arch Neurol 46: 895–898
Koppel BS, Wormser GP, Tuchman AJ et al. (1985) Central nervous system involvement in patients with acquired immune deficiency syndrome (AIDS). Acta Neurol Scand 71: 337–353
Lambert JS, Seidlin M, Reichman RC et al. (1990) 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. N Engl J Med 322:1330–1340
Lanska MJ, Lanska DJ, Schmidley JW (1988) Syphilitic polyradiculopathy in an HIV-positive man. Neurology 38: 1297–1301
Larsen RA, Leal MAE, Chan LS (1990) Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med 113: 183–187
Leport C, Raffi F, Matheron S et al. (1988) Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immune deficiency syndrome. Am J Med 84: 94–100
Levy RM, Pons VG, Rosenblum ML (1983) Intracerebral mass lesions in the acquired immunodeficiency syndrome (AIDS). N Engl J Med 309: 1454–1455
Levy RM, Bredesen DE, Rosenblum ML (1985a) Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 62:475–495
Levy RM, Pons VG, Rosenblum ML (1985b) Central nervous system mass lesions in the acquired immunodeficiency syndrome ( AIDS ). J Neurosurg 61: 9–16
Levy RM, Rosenbloom S, Perret LV (1986) Neuroradiologic findings in AIDS: a review of 200 cases. AJNR 7: 833–839
Levy RM, Russel E, Yungbluth M et al. (1991) The efficacy of image quided stereotaxis brain biopsy in neurologically symptomatic AIDS patients. Abstr WB 27. 7th International Conference on AIDS, Florence
Lipkin WI, Parry G, Kiprov D et al. (1985) Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology (NY) 35: 1479–1483
Luft B J, Remington JS (1985) Toxoplasmosis of the central nervous system. Curr Clin Top Infect Dis 6: 315–358
Luft B J, Remington JS (1987) Toxoplasmic encephalitis. J Infect Dis 157: 1–6
Maclean C, Flegg PJ, Kilpatrick DC (1990) Anti-cardiolipin antibodies and HIV infection. Clin Exp Immunol 81: 263–266
Mark AS, Atlas SW (1989) Progressive multifocal leukoencephalopathy in patients with AIDS: appearance on MR images. Radiology 173: 517–520
Mascola L, Lieb L, Chiu J et al. (1988) Listeriosis: an uncommon opportunistic infection in patients with acquired immunodeficiency syndrome. A report of five cases and a review of the literature. Am J Med 84: 162–164
Marshall DW, Brey RL, Cahill WT et al. (1988) Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 45: 954–958
McArthur JC (1987) Neurologic manifestations of AIDS. Medicine (Baltimore) 66: 407–437
McArthur JC, Cohen BA, Selnes OA et al. (1989) Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1 infected individuals: results from the multicenter AIDS cohort study. Ann Neurol 26: 601–611
McGabe RE, Remington JS (1990) Toxoplasma gondii. In: Mandell GL, Douglas RG, Bennett JE (eds) Principles and practice of infectious diseases, 3rd edn. Churchill Livingstone, New York, pp 2090–2102
Miller RG, Storey JR, Greco CM (1990) Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 40: 569–574
Navia BA, Price RW (1987) The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol 44: 65–69
Navia BA, Petito CK, Gold JWM, Cho ES, Jordan BD, Price RW (1986 a) Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol 19: 224–238
Navia BA, Jordan BD, Price RW (1986b) The AIDS dementia complex. I. Clinical features. Ann Neurol 19: 517–524
Navia BA, Cho ES, Petito CK et al. (1986c) The AIDS dementia complex. II. Neuropathology. Ann Neurol 19: 525–535
Olsen WL, Longo FM, Mills CM, Norman D (1988) White matter disease in AIDS: findings at magnetic resonance imaging. Radiology 169: 445–448
Perdices M, Brew BJ, Grunseit A et al. (1991) Neuropsychological and neurologic features of impairment in AIDS (Abstr ThB 87). 7th International Conference on AIDS, Florence
Petito CK, Navia B A, Cho ES et al. (1985) Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with acquired immunodeficiency syndrome. N Engl J Med 312: 874–879
Pons VG, Jacobs RA, Hollander H (1988) Nonviral infections of the central nervous system in patients with acquired immunodeficiency syndrome. In: Rosenblum ML, Levy RM, Bredesen DE (eds) AIDS and the nervous system. Raven, New York, pp 263–283
Portegies P, de Gans J, Lange JMA et al. (1989a) Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. Br Med J 299:819–821
Portegies P, Epstein LG, Tjong A, Hung S et al. (1989 b) Human immunodeficiency virus type 1 antigen in cerebrospinal fluid: correlation with clinical neurologic status. Arch Neurol 46:261–264
Portegies P, Algra PR, Hollak CEM et al. (1991) Response to cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1: 680–681
Price RW, Brew BJ (1988) The AIDS dementia complex. J Infect Dis 158: 1079–1083
Price RW, Brew BJ, Sidtis J et al. (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239: 586–592
Ramsay RG, Geremia GK (1988) CNS complications of AIDS: CT and MR findings. AJR 151: 449–454
Richardson EP Jr (1961) Progressive multifocal leukoencephalopathy. N Engl J Med 265: 815–823
Rosenblum ML, Levy RM, Bredesen DE et al. (1988) Primary central nervous system lymphomas in patients with AIDS. Ann Neurol 23 Suppl: S13–S16
Rosenblum M, Scheck AC, Cronin K et al. (1989) Dissociation of AIDS related vacuolar myelopathy and productive HIV-1 infection of the spinal cord. Neurology 39: 892–896
Said G, Lacroix C, Chemouilli P et al. (1991) Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 29: 139–146
Schaumburg HH, Arezzo J, Berger A (1990) Dideoxycytidine (ddC) neuropathy in HIV infections: a report of 52 patients (Abstr). Neurology 40 Suppl: 248
Schmitt FA, Bigley JW, McKinnis R et al. (1988) Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 319: 1573–1578
Selnes OA, Miller E, McArthur JC et al. (1990) HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. Neurology 40: 204–208
Selnes OA, McArthur JC, McArthur JH, Saah A (1991) Incident HIV-dementia in the multicenter AIDS cohort study: pattern of cognitive decline (Abstr). Neuroscience of HIV infection Conference, Padova
Simpson DM, Bender AN (1988) HIV-associated myopathy: analysis of 11 patients. Ann Neurol 24: 79–84
Simpson DM, Wolfe DE (1991) Neuromuscular complications of HIV infection and its treatment. AIDS 5: 917–926
Snider WD, Simpson DM, Nielsen S et al. (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14: 403–418
So YT, Beckstead JH, Davis RI (1986) Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann Neurol 20: 566–572
So YT, Holtzman DM, Abrams DI et al. (1988) Peripheral neuropathy associated with AIDS. Arch Neurol 45: 945–948
Sugar AM, Stern JJ, Dupont B (1990) Overview: treatment of cryptococcal meningitis. Rev Infect Dis 12: S338–S348
Tindall B, Cooper DA (1991) Primary HIV infection: host responses and intervention strategies. AIDS 5: 1–14
Wilkie FL, Eisdorfe C, Morgan R et al. (1990) Cognition in early human immunodeficiency virus infection. Arch Neurol 47: 433–440
Wong MC, Suite NA, Labar DR (1990) Seizures in human immunodeficiency virus infection. Arch Neurol 47: 640–642
Yarchoan R, Mitsuya H, Thomas RV et al. (1989) In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxyinosine. Science 245: 412–415
ZuRhein G, Chou SM (1965) Particles resembling papovaviruses in human cerebral demyelinating disease. Science 148: 1477–1479
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Portegies, P. (1993). Clinical Neurology in AIDS. In: Artigas, J., Grosse, G., Niedobitek, F. (eds) The Central Nervous System in AIDS. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77732-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-77732-5_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77734-9
Online ISBN: 978-3-642-77732-5
eBook Packages: Springer Book Archive